Skip to menu Skip to content Skip to footer

2009

Journal Article

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

Crawford, D. H. G., Murphy, T. L., Ramm, L. E., Fletcher, L. M., Clouston, AD, Anderson, G. J., Subramaniam, V. N., Powell, L. W. and Ramm, G. A. (2009). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology, 49 (2), 418-425. doi: 10.1002/hep.22650

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

2009

Conference Publication

Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis

McPherson, S., Cowin, G., O'Rourke, P., Volp, A., Horsfall, L., Burke, L., Jonsson, J., Clouston, A., Fawcett, J., Galloway, G., Benson, M. and Powell, E. (2009). Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen Denmark, Apr 22-26, 2009. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(09)61011-4

Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis

2008

Journal Article

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma

Smith, Eric, De Young, Neville J., Pavey, Sandra J., Hayward, Nicholas K., Nancarrow, Derek J., Whiteman, David C., Smithers, B. Mark, Ruszkiewicz, Andrew R., Clouston, Andrew D., Gotley, David C., Devitt, Peter G., Jamieson, Glyn G. and Drew, Paul A. (2008). Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma. Molecular Cancer, 7 (1) 75, 75.1-75.12. doi: 10.1186/1476-4598-7-75

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma

2008

Conference Publication

Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection

Jilbert, A. R., Mason, W. S., Low, H. C., Xu, C., Scougall, C., Grosse, A., Clouston, A., Chavez, D. and Lanford, R. (2008). Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection

2008

Conference Publication

Pre-treatment with cholic acid reduces MCD-diet induced liver injury

London, R. M., Hurrell, J., Ho, V., Sesha, J., Coulter, S., Clouston, A., Liddle, C. and George, J. (2008). Pre-treatment with cholic acid reduces MCD-diet induced liver injury. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Pre-treatment with cholic acid reduces MCD-diet induced liver injury

2008

Journal Article

Recognition of genetic factors influencing the progression of Hepatitis C

Jonsson, Julie R., Purdie, David M., Clouston, Andrew D. and Powell, Elizabeth E. (2008). Recognition of genetic factors influencing the progression of Hepatitis C. Molecular Diagnosis and Therapy, 12 (4), 209-218. doi: 10.2165/1250444-200812040-00002

Recognition of genetic factors influencing the progression of Hepatitis C

2008

Journal Article

Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays

Nancarrow, D.J., Handoko, H. Y., Smithers, B.M., Gotley, D. C., Drew, P.A., Watson, D.I., Clouston, A. D., Hayward, N. and Whiteman, D. C. (2008). Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Research, 68 (11), 4163-4172. doi: 10.1158/0008-5472.CAN-07-6710

Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays

2008

Journal Article

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis

McPherson, S., Jonsson, J. R., Barrie, H. D., O'Rourke, P., Clouston, A. D. and Powell, E. (2008). Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis. Journal of Hepatology, 49 (6), 1046-1054. doi: 10.1016/j.jhep.2008.06.022

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis

2008

Conference Publication

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

Bridle, K. R., Sobbe, A. L., Fletcher, L. M., Clouston, A. D. and Crawford, D. H. G. (2008). Multiple pathways to hepatic fibrosis are inhibited by rapamycin. Australian Gastroenterology Week 2008, Brisbane, Qld, Australia, 22-25 October 2008. Carlton South, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

2008

Conference Publication

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

Crawford, Darrell H., Murphy, Therese L., Ramm, Louise E., Fletcher, Linda M., Clouston, Andrew D., Anderson, Gregory J., Subramaniam, V. Nathan, Powell, Lawrie W. and Ramm, Grant A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, U.S.A., 31 October-4 November 2008. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/hep.22641

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

2008

Journal Article

Obesity and steatosis influence serum and hepatic inflammatory in chronic Hepatitis C

Jonsson, J. R., Barrie, H. D., O'Rourke, P., Clouston, A. D. and Powell, E. E. (2008). Obesity and steatosis influence serum and hepatic inflammatory in chronic Hepatitis C. Hepatology, 48 (1), 80-87. doi: 10.1002/hep.22311

Obesity and steatosis influence serum and hepatic inflammatory in chronic Hepatitis C

2008

Journal Article

Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection

Laurence, J., Wang, C., Park, E., Buchanan, A., Clouston, A. D., Alen, R., Mccaughan, G., Bishop, G. and Sharland, A. (2008). Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection. Transplantation, 85 (9), 1357-1361. doi: 10.1097/TP.0b013e31816fc27f

Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection

2008

Journal Article

Magnetic resonance imaging and spectroscopy for monitoring liver steatosis

Cowin, Gary J., Jonsson, Julie R., Bauer, Judith D., Ash, Susan, Ali, Azmat, Osland, Emma J., Purdie, David M., Clouston, Andrew D., Powell, Elizabeth E. and Galloway, Graham J. (2008). Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. Journal of Magnetic Resonance Imaging, 28 (4), 937-945. doi: 10.1002/jmri.21542

Magnetic resonance imaging and spectroscopy for monitoring liver steatosis

2008

Conference Publication

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

Crawford, D. H. G., Murphy, T. L., Ramm, L. E., Fletcher, L. M., Clouston, A. D., Anderson, G. J., Subramaniam, V. N., Powell, L. W. and Ramm, G. A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. AGW 2008: Australian Gastroenterology Week 08, Brisbane, QLD, Australia, 22-25 October 2008. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1111/j.1440-1746.2008.05613.x

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

2008

Conference Publication

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

Popa, C., Bridle, K. R., Morgan, M. L., Clouston, A. D., Fletcher, L. M. and Crawford, D. H. G. (2008). Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April, 2008. Ireland: Elsevier. doi: 10.1016/S0168-8278(08)60467-5

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

2007

Journal Article

IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract

Burman, Angela C., Banovic, Tatjana, Kuns, Rachel D., Clouston, Andrew D., Stanley, Amanda C., Morris, Edward S., Rowe, Vanessa, Bofinger, Helen, Skoczylas, Renae, Raffelt, Neil, Fahy, Olivier, McColl, Shaun R., Engwerda, Christian R., McDonald, Kelli P. A. and Hill, Geoffrey R. (2007). IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood, 110 (3), 1064-1072. doi: 10.1182/blood-2006-12-063982

IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract

2007

Conference Publication

Confocal endomicroscopy in the evaluation of celiac disease - A prospective validation study

Leong, Rupert W., Koo, Jenn H., Meredith, Christopher G., Clouston, Andrew D. and Merrett, Neil D. (2007). Confocal endomicroscopy in the evaluation of celiac disease - A prospective validation study. Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington Dc, May 19-24, 2007. NEW YORK: MOSBY-ELSEVIER. doi: 10.1016/j.gie.2007.03.829

Confocal endomicroscopy in the evaluation of celiac disease - A prospective validation study

2007

Journal Article

Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others

Clouston, Andrew D., Jonsson, Julie R. and Powell, Elizabeth E. (2007). Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clinics in Liver Disease, 11 (1), 173-189. doi: 10.1016/j.cld.2007.02.007

Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others

2007

Journal Article

An assessment of the role of SREBP 1 C in the pathogenesis of HCV-related steatosis

McPhersonS, Jonsson, JR, BarrieHD, CloustonAD and PowellEE (2007). An assessment of the role of SREBP 1 C in the pathogenesis of HCV-related steatosis. Hepatology, 46 (4), 438A-438A.

An assessment of the role of SREBP 1 C in the pathogenesis of HCV-related steatosis

2007

Book Chapter

Fatty liver as a cofactor for other liver diseases

McPherson, S., Clouston, A.D., Jonsson, J.R. and Powell, E. (2007). Fatty liver as a cofactor for other liver diseases. International Hepatology Updates: Nonalcoholic steatohepatitis (NASH). (pp. 161-174) edited by Bataller, R. and Caballeria, J.. Spain: Permanyer Publications.

Fatty liver as a cofactor for other liver diseases